Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia

  NCSF group (n = 55) CSF group (n = 71) p
Age 55.73 ± 11.93 55.85 ± 11.06 0.954
Male 34 (61.8%) 60 (84.5%) 0.004
BMI 26.29 ± 4.97 27.15 ± 3.41 0.251
Smoking history 24 (43.6%) 45 (63.4%) 0.021
Anti-platelet drugs 30 (54.5%) 36 (50.7%) 0.402
β-blockers 19 (34.5%) 23 (32.4%) 0.474
ACE inhibitors 6 (10.9%) 5 (7%) 0.326
ARBs 8 (14.5%) 10 (14.1%) 0.569
Statins 26 (47.3%) 31 (43.7%) 0.411
Hypertension 36 (65.5%) 42 (59.2%) 0.296
Diabetes 13 (23.6%) 10 (14.1%) 0.276
LVEF 64.11 ± 4.20 48.68 ± 4.16 0.264
LVEDd 48.44 ± 4.33 48.68 ± 4.16 0.753
CAE in LAD (%) 29 (52.7%) 52 (73.2%) 0.044
CAE in LCX (%) 14 (25.5%) 41 (57.7%) 0.001
CAE in RCA (%) 31 (56.4%) 52 (73.2%) 0.111
CAE in 1 vessel 33 (60%) 21 (29.6%) 0.001
CAE in 2 vessels 15 (27.3%) 26 (36.6%) 0.001
CAE in 3 vessels 7 (12.7%) 24 (33.8%) 0.001